RCT: Pembrolizumab with Preoperative Radiotherapy Shows Potential in Stage III Soft Tissue Sarcoma
SPECIALTIES,
Background: Patients with locally advanced, high-grade soft tissue sarcomas of the extremity often face a high risk of…
Adding pembrolizumab to preoperative radiotherapy and surgery improves disease-free survival for patients with stage III soft tissue sarcomas of the extremity
Grey Horizon,
Findings from the SU2C-SARC032 trial, conducted by the Sarcoma Alliance for Research through Collaboration (SARC) in 20…
Adding Pembrolizumab Ups Survival in Stage III Undifferentiated Sarcoma
Physician's Weekly,
THURSDAY, Nov. 21, 2024 (HealthDay News) — For patients with stage III undifferentiated pleomorphic sarcoma or dedifferentiated…
Pembrolizumab, an immunotherapy medication, improves outcomes for patients with soft tissue sarcoma
BiotechReality.com,
The results of the SU2C-SARC032 clinical trial, which was conducted by researchers from the University of Pittsburgh, UPMC…